ArticleTherapeutic advances in gastroenterology2025

Association of early therapeutic drug monitoring of adalimumab with biologic remission and drug survival in Crohn's Disease.

José Luis Rueda García et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.